2020
DOI: 10.1016/j.acax.2020.100039
|View full text |Cite
|
Sign up to set email alerts
|

New planar assay for streamlined detection and quantification of β-glucuronidase inhibitors applied to botanical extracts

Abstract: The inhibition of the β-glucuronidase released from gut bacteria is associated with specific health-related benefits. Though a number of β-glucuronidase inhibition assays are currently in use, none of them can directly measure the relevant activity of each single constituent in a complex mixture, without prior separation and tedious isolation of the pure compounds. Thus, the hyphenation of the high performance thin layer chromatography (HPTLC) technique with a β-glucuronidase inhibition assay was investigated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 51 publications
0
7
0
Order By: Relevance
“…The β-glucuronidase inhibition assay was run as described recently ( Mahran et al, 2020 ) The chromatogram was pre-wetted with potassium phosphate buffer (0.5 ml; 9.34 mg/ml K 2 HPO 4 and 6.31 mg/ml KH 2 PO 4 ; green nozzle, level 6). Then, 750 µL enzyme solution (25 U/ml in potassium phosphate buffer with 1 mg/ml BSA) were sprayed onto the chromatogram (green nozzle, level 6).…”
Section: Methodsmentioning
confidence: 99%
“…The β-glucuronidase inhibition assay was run as described recently ( Mahran et al, 2020 ) The chromatogram was pre-wetted with potassium phosphate buffer (0.5 ml; 9.34 mg/ml K 2 HPO 4 and 6.31 mg/ml KH 2 PO 4 ; green nozzle, level 6). Then, 750 µL enzyme solution (25 U/ml in potassium phosphate buffer with 1 mg/ml BSA) were sprayed onto the chromatogram (green nozzle, level 6).…”
Section: Methodsmentioning
confidence: 99%
“…In particular, the detection of estrogen-like, androgen-like, genotoxic, and agonistic/antagonistic effects, which have been developed recently [ 46 ], should be of interest. As demonstrated in previous studies, the individual active compounds can further be characterized by HPTLC-HESI-HRMS and elucidated in its structure [ 64 , 70 ]. Quantification of the discovered activities can be performed by external standards or a well-known reference (equivalency calculation), when a standard compound is not available or the bioactive compound is unknown/unidentified [ 63 , 71 ].…”
Section: Resultsmentioning
confidence: 99%
“…The PC was tetracycline (0.5, 1.5, and 3 μL/band, 0.004 mg/mL in ethanol). For the β-glucuronidase assay [ 64 ], 0.5 mL potassium phosphate buffer (0.1 M, pH 7.0, for prewetting) and then 3.0 mL of β-glucuronidase solution (25 U/mL in previous buffer) were sprayed (yellow nozzle), followed by incubation at 37 °C for 15 min. For generation of the colorless (white) inhibition bands on an indigo-blue background, the plate was sprayed (red nozzle) with 1.0 mL 5-bromo-4-chloro-3-indolyl-β- d -glucuronide solution (2 mg/mL in water) and incubated at 37 °C for 1 h. The PC was d -saccharolactone (0.5, 1.5, and 3 μL/band, 0.1 mg/mL in water).…”
Section: Methodsmentioning
confidence: 99%
“…Furthermore, high intestinal microflora β-GUS activity has been recognized as an important factor that can increase the risk of a panel of intestinal diseases, such as colorectal inflammation and colorectal cancer [28]. Therefore, it is urgent and necessary to find more efficacious EcGUS inhibitors possessing good safety profiles for the prevention and treatment of irinotecan-induced intestinal toxicity and other β-GUS-associated intestinal dysfunction [29,30].…”
Section: Discussionmentioning
confidence: 99%